AlphAIalphai — Financial news for AI agents
investing.comAUG 134 min read$CLBT

Why is Cellebrite stock plunging today?

Cellebrite (CLBT) shares fell about 28% in pre-open after Q2 2026 results and a leadership change. EPS was $0.11 vs $0.07 consensus, but revenue missed at $131.14M vs $131.87M. Guidance was cut: FY 2026 ARR to $550M-$560M and revenue to $550M-$560M, below $568M consensus. CEO change and a Form 144 insider sale added pressure.

Original reporting
investing.com
Published Aug 13, 2026, 11:42 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 12:10 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefEarnings
Primary signal
$CLBT
Bearish
high confidence
Mentioned
$CLBT
Relevance
9/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$CLBTBearishHigh
01

Why it matters

The combination of a revenue miss, lower full-year and Q3 revenue/ARR outlook, and an immediate leadership handover is a direct catalyst for repricing forward expectations and near-term risk.

02

Market read

Traders have a fresh, quantified guidance cut and leadership change to update models immediately, explaining the outsized pre-open drop.

03

What to watch

The article does not quantify backlog, customer churn, or contract timing; traders may be reacting to guidance optics more than underlying demand.

Relevance 9/10Novelty 9/10Timing: pre-market today after Q2 results and guidance cut

Background

Cellebrite reported Q2 2026 results before the open and simultaneously announced a CEO change, alongside a revenue and guidance reset.

Company-level read

Ticker impact

$CLBTBearishHigh confidence
Context

Cellebrite shares fell 27.9% pre-open after Q2 results beat EPS but revenue missed and fiscal 2026 guidance was cut, plus an immediate CEO change.

Expected impact

Bearish bias for the next several sessions as traders reprice ARR, Q3 conversions, and management execution risk.

Evidence & confidence

The article cites specific guidance ranges (ARR and revenue), Q3 revenue shortfall, and an immediate CEO succession, all of which directly affect forward cash-flow expectations.

Market effects

Sector

Could pressure sentiment toward digital forensics and surveillance software names if ARR conversion concerns spread, but the article is single-company focused.

Regional

No regional spillover described; move is attributed to company-specific developments.

Global

Limited global relevance beyond the company’s own guidance and leadership transition.

Counterpoint

What could challenge this read

EPS beat and a new CEO could stabilize execution, so the selloff may over-discount a temporary sales-cycle/conversion slowdown.

Key entities

  • public_company
    Cellebrite

    Subject of the article; stock dropped sharply after Q2 results, guidance cuts, and CEO succession.

  • executive
    Shiven Ramji

    Took over as CEO effective immediately, succeeding Thomas E. Hogan.

  • executive
    Thomas E. Hogan

    Planned to sell about 339,000 shares per a Form 144 filing disclosed in the article.

Read at source← All news

Related articles

AUG 13
$CPKMedAI 8/10

Chesapeake Utilities (CPK) Q2 2026 Earnings Call Transcript

Chesapeake Utilities (CPK) reported Q2 2026 adjusted net income of $25.4 million, up 5% year over year, and adjusted EPS of $1.05. Management raised 2026 capital guidance to $550 million to $600 million and expects 2028 EPS of $7.75 to $8.00. It also discussed the $1.2 billion Florida Energy Pathway project and reaffirmed efficiency and dividend plans.

fool.com10 min